Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 2
- Next page
Title Sort ascending | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Value of MMA crossmatch? | Tong TN, Cserti-Gazdewich CM, Branch DR | 2016 | Transfus Med | View Value of MMA crossmatch? | Researchers | Basic research |
Validation of sterility testing of cord blood: Challenges and results | Ramirez-Arcos S, Kou Y, Yang L, Perkins H, Taha M, Halpenny M, Elmoazzen H | 2015 | Transfusion | View Validation of sterility testing of cord blood: Challenges and results | Blood operators | New or improved product or process |
Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Molnar AO, van Walraven C, McArthur E, Fergusson D, Garg AX, Knoll G | 2016 | Can J Kidney Health Dis | View Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Regulators | New or improved product or process |
Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Liwski R, Clarke G, Cheng C, Abidi SSR, Abidi SR, Quinn JG | 2023 | Vox Sang | View Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Health care providers | New or improved product or process |
Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Goldman M, Uzicanin S, Yi QL, Acker JP, Ramirez-Arcos S | 2012 | Transfusion | View Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Blood operators | New or improved product or process |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C | 2021 | Res Pract Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Mouta Nunes de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, Vitiello Teixeira G, Saraiva Pedro R, Roberto Gomes Takey P, Kegele Lignani L, Reis Xavier J, Cardoso Doria da Gama V, Amorim Filho L, Emoingt Furtado B, Santa Maria A, Dahrug Barros T, Neves Waite Freitas L, Dos Santos Pereira T, Lima Abreu D, Bernardes Ramos M, Gabe C, Arnold D, William Smith J, Nazy I, Lourdes de Sousa Maia M | 2022 | Vaccine | View Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia | Klok FA, Pai M, Huisman MV, Makris M | 2022 | Lancet Haematol | View Vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Chambers C, Hickman R, Sabaiduc S, Chan T, Jassem A, Rose C, Krajden M, Skowronski DM, Petric M, De Serres G, Martineau C, Charest H, Winter A-L, Gubbay JB, Dickinson JA, Fonseca K, Drews SJ, Bastien N, Li Y | 2018 | Clin Infect Dis | View Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Researchers | Clinical research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Olasupo OO, Haddix C, Nakar C, Maahs J, Greist A, Ghafoor A, Donfield SM, Iorio A, Shapiro AD | 2022 | Eur J Haematol | View Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Health care providers | Benchmarking and standard setting |
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators | 2013 | Transfusion | View Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk | Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM | 2020 | Transfus Med | View Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk | Health care providers | Clinical research |
Utilisation des produits sanguins CMV négatifs | Ryan J | 2017 | Blood.ca website | View Utilisation des produits sanguins CMV négatifs | Health care providers | Benchmarking and standard setting |
Using umbilical cord blood for regenerative therapy: Proof or promise? | Allan DS | 2020 | Stem Cells | View Using umbilical cord blood for regenerative therapy: Proof or promise? | Researchers | Clinical research |
Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-?TP-L309C, a recombinant IgG1 Fc hexamer | Lewis BJB, Ville J, Blacquiere M, Cen S, Spirig R, Zuercher AW, Käsermann F, Branch DR | 2019 | BMC Immunol | View Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-?TP-L309C, a recombinant IgG1 Fc hexamer | Researchers | Basic research |
Using simulation to evaluate a blood supply network in the Canadian maritime provinces | Blake J, Hardy M | 2013 | J Enterp Inf Manag | View Using simulation to evaluate a blood supply network in the Canadian maritime provinces | Researchers | New or improved product or process |
Using simulation for strategic blood supply chain design in the Canadian prairies | Blake J, McTaggart K | 2016 | Proceedings of the 6th International Conference on SIMULTECH | View Using simulation for strategic blood supply chain design in the Canadian prairies | Blood operators | New or improved product or process |
Using Raman spectroscopy to assess hemoglobin oxygenation in red blood cell concentrate: an objective proxy for morphological index to gauge the quality of stored blood? | Atkins CG, Schulze HG, Chen D, Devine DV, Blades MW, Turner RF | 2017 | Analyst | View Using Raman spectroscopy to assess hemoglobin oxygenation in red blood cell concentrate: an objective proxy for morphological index to gauge the quality of stored blood? | Researchers | New or improved product or process |
Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Scott AN, Buchan SA, Kwong JC, Drews SJ, Simmonds KA, Svenson LW | 2019 | BMJ Open | View Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Researchers | Clinical research |
Using pharmacokinetics to individualize hemophilia therapy | Iorio A | 2017 | Hematology Am Soc Hematol Educ Program | View Using pharmacokinetics to individualize hemophilia therapy | Health care providers | Clinical research |
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review | Yu JK, Iorio A, Edginton AN, Wapps co?investigators | 2019 | Res Pract Thromb Haemost | View Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review | Researchers | Clinical research |
Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Day D, Lin Y | 2021 | Ontario Regional Blood Coordinating Network September 2021 Newsletter | View Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Health care providers | Benchmarking and standard setting |
Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein–Barr virus in Canada: A cross-sectional study | Mabilangan C, Burton C, O'Brien S, Plitt S, Eurich DT, Preiksaitis J | 2020 | JAMMI | View Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein–Barr virus in Canada: A cross-sectional study | Researchers | Clinical research |
Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease | Tse E, Khurana R, Clarke G, Sia W | 2018 | Obstet Med | View Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease | Health care providers | New or improved product or process |
User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study | Germini F, Borg Debono V, Page D, Zuk V, Kucher A, Cotoi C, Hobson N, Sevestre M, Skinner MW, Iorio A | 2022 | JMIR Hum Factors | View User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study | Researchers | Benchmarking and standard setting |
Use of selective phenotyping and genotyping to identify rare blood donors in Canada | Tordon B, Montemayor C, Clarke G, O'Brien SF, Goldman M | 2023 | Vox Sang | View Use of selective phenotyping and genotyping to identify rare blood donors in Canada | Blood operators | Clinical research |
Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Kirpalani HM, Prokopchuk-Gauk O, Heddle NM | 2022 | JAMA Pediatr | View Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Health care providers | New or improved product or process |
Use of cytomegalovirus (CMV) seronegative blood products | Ryan J | 2017 | Blood.ca website | View Use of cytomegalovirus (CMV) seronegative blood products | Health care providers | Benchmarking and standard setting |
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies | Maganti HB, Kirkham AM, Bailey AJM, Shorr R, Kekre N, Pineault N, Allan DS | 2022 | Cytotherapy | View Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies | Researchers | Clinical research |
Use of a Monocyte Monolayer Assay to Evaluate Fc gamma Receptor-mediated Phagocytosis | Tong T, Branch D | 2017 | J Vis Exp | View Use of a Monocyte Monolayer Assay to Evaluate Fc gamma Receptor-mediated Phagocytosis | Researchers | Basic research |
Updated Understanding of Platelets in Thrombosis and Hemostasis: The Roles of Integrin PSI Domains and their Potential as Therapeutic Targets | MacKeigan DT, Ni T, Shen C, Stratton TW, Ma W, Zhu G, Bhoria P, Ni H | 2020 | Cardiovasc Hematol Disord Drug Targets | View Updated Understanding of Platelets in Thrombosis and Hemostasis: The Roles of Integrin PSI Domains and their Potential as Therapeutic Targets | Researchers | Basic research |
Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!! | Seghatchian J, Acker JP, Putter JS | 2020 | Transfus Apher Sci | View Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!! | Researchers | New or improved product or process |
Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS | 2018 | Transfusion | View Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Health care providers | Clinical research |
Unraveling the IVIG mystique | Branch DR | 2013 | Transfusion | View Unraveling the IVIG mystique | Researchers | Other |
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder | Venier LM, Clerici B, Bissola AL, Modi D, Jevtic SD, Radford M, Mahamad S, Nazy I, Arnold DM | 2023 | Int J Hematol | View Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder | Researchers | Clinical research |
Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin | Branch DR, Scofield TL, Moulds JJ, Swanson JL | 2011 | Transfusion | View Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin | Researchers | Basic research |
Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy | Wang KK, Charles C, Heddle NM, Arnold E, Molnar L, Arnold DM | 2014 | Health Expect | View Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy | Health care providers | Clinical research |
Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID-19: A qualitative study | Holloway K | 2022 | Vox Sang | View Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID-19: A qualitative study | Researchers | Ethical, legal & social implications research |
Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study | Lane SJ, Sholapur NS, Yeung CH, Iorio A, Heddle NM, Sholzberg M, Pai M | 2016 | Haemophilia | View Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study | Health care providers | Other |
Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Patterson S, Sandercock N, Verhovsek M | 2022 | Am J Hematol | View Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Health care providers | Clinical research |
Understanding iron depletion and overload in blood donors | O'Brien SF, Goldman M | 2017 | ISBT Sci Ser | View Understanding iron depletion and overload in blood donors | Blood operators | Clinical research |
Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Schubert P, Johnson L, Marks DC, Devine DV | 2018 | Front Med | View Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Researchers | Basic research |
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis | Cannon JW, Igra NM, Borge PD, Cap AP, Devine D, Doughty H, Geng Z, Guzman JF, Ness PM, Jenkins DH, Rajbhandary S, Schmulevich D, Stubbs JR, Wiebe DJ, Yazer MH, Spinella PC | 2022 | Transfusion | View U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis | Health care providers | Clinical research |
Two-year follow-up of donors in a large national study of ferritin testing | Goldman M, Uzicanin S, Osmond L, Yi Q-L, Scalia V, O'Brien SF | 2018 | Transfusion | View Two-year follow-up of donors in a large national study of ferritin testing | Researchers | Clinical research |